Find public news by keyword, exact ticker, category and date.
Open a ticker page for its news coverage. The news search below stays a text search.
23 results loaded, newest first. End of these results.
Adj EPS: $2.59 (est $2.52) - Sales: $25.40B (est $25.4B) - Medicine Rev: $16.76B (est $16.59B) - Darzalex Rev: $4.24B (est $4.31B) - Tremfya Rev: $2.40B (est $2.21B) - MedTech Sales: $8.64B (est $8.77B) - Sees FY Sales: $101B To $101.4B (est $100.8B To $101.4B) - Sees FY Adj EPS: $11.05 To $11.15 (est $10.96 To $11.11)
(This story was generated using AI and automation, please see disclaimer ) Overview US healthcare conglomerate's Q3 sales rose 5.9%, slightly beating analyst expectations Adjusted EPS for Q3 was $2.59, beating analyst expectations Company raised 2026 sales and adjusted EPS guidance Outlook Johnson & Johnson raises 2026
For best results when printing this announcement, please click on link below: Johnson & Johnson reports Q3 2026 results, raises 2026 guidance 2026 Third-Quarter reported sales growth of 5.9% to $25.4 Billion with operational growth of 6.0%* and adjusted operational growth of 6.1% 2026 Third-Quarter earnings per share (
(Repeats BUZZ published on Monday with no changes) * Johnson & Johnson shares up 0.6% at $263.00 on Mon ahead of qtrly results before the bell, with investors watching for a rebound in its medtech unit * The healthcare conglomerate is expected to post Q3 rev of $25.28 bln and adj EPS of $2.54, down from EPS of $2.80 bu
* Johnson & Johnson shares up 0.6% at $263.00 on Mon ahead of qtrly results before the bell, with investors watching for a rebound in its medtech unit * The healthcare conglomerate is expected to post Q3 rev of $25.28 bln and adj EPS of $2.54, down from EPS of $2.80 but up from revenue of $23.99 bln a year ago, per LSE
Earnings season kicks off this week as several of the largest financial companies report quarterly financial results. The week is a big one for the Dow Jones Industrial Average, with five of its 30 components reporting. Dow Jones Industrial Average Gets Spotlight To kick off earnings season, the Dow Jones Industrial Av
Johnson & Johnson is scheduled to report Q3'26 results on October 13 before the market opens. Revenue is estimated at 25.38 billion USD and EPS at 2.52 USD.
Penguin Solutions (NASDAQ: PENG ) reported fourth-quarter financial results on Tuesday. The transcript from the company's fourth-quarter earnings call has been provided below. APIs provide real-time access to earnings call transcripts and financial data. Visit to learn more. View the webcast at Summary Full Transcript
Enovis (NYSE: ENOV ) reported second-quarter financial results on Thursday. The transcript from the company's second-quarter earnings call has been provided below. APIs provide real-time access to earnings call transcripts and financial data. Visit to learn more. View the webcast at Summary Enovis reported second quart
JNJ (Johnson & Johnson) is set to announce its Q3'26 results on October 13, before the market opens. The earnings are expected to be disclosed at 6:45 AM ET (10:45 AM UTC).For Q3'26, revenue estimate is 25.36 billion USD with EPS (earnings per share) anticipated at 2.72 USD. Learn more details at J…
Peloton Interactive (NASDAQ: PTON ) held its fourth-quarter earnings conference call on Thursday. Below is the complete transcript from the call. This content is powered APIs. For comprehensive financial data and transcripts, visit View the webcast at Summary Peloton Interactive reported positive financial performance
Golub Capital BDC (NASDAQ: GBDC ) released third-quarter financial results and hosted an earnings call on Tuesday. Read the complete transcript below. APIs provide real-time access to earnings call transcripts and financial data. Visit to learn more. Access the full call at Summary Golub Capital BDC reported improved f
BofA Securities raised its price target on Johnson & Johnson NYSE:JNJ to $278 from $263 while keeping a Neutral rating, lifting its forecasts for Icotyde and updating its model for recent in-process research and development charges. J&J shares were down 0.22% in premarket.The new target applies 22x…
Henry Schein (NASDAQ: HSIC ) held its second-quarter earnings conference call on Tuesday. Below is the complete transcript from the call. This content is powered APIs. For comprehensive financial data and transcripts, visit Access the full call at Summary Henry Schein Inc reported strong financial performance in the se
Worksport (NASDAQ: WKSP ) reported second-quarter financial results on Tuesday. The transcript from the company's second-quarter earnings call has been provided below. This transcript is brought to you APIs. For real-time access to our entire catalog, please visit for a consultation. The full earnings call is available
B2Gold (TSX: BTO ) held its second-quarter earnings conference call on Friday. Below is the complete transcript from the call. APIs provide real-time access to earnings call transcripts and financial data. Visit to learn more. View the webcast at Summary B2Gold Corporation reported consolidated gold production of appro
B2Gold (AMEX: BTG ) reported second-quarter financial results on Friday. The transcript from the company's second-quarter earnings call has been provided below. APIs provide real-time access to earnings call transcripts and financial data. Visit to learn more. The full earnings call is available at Summary B2Gold Corpo
Icecure Medical (NASDAQ: ICCM ) released second-quarter financial results and hosted an earnings call on Wednesday. Read the complete transcript below. This content is powered APIs. For comprehensive financial data and transcripts, visit Access the full call at Summary Icecure Medical reported a 45% year-over-year reve
Macy's said second-quarter net sales, comparable sales, adjusted EBITDA and adjusted diluted EPS all exceeded guidance. The company reported 2.7% comparable sales growth and said adjusted EPS was 63 cents, helped by tariff refunds.
Core & Main reported second-quarter fiscal 2026 net sales up 2.5% to about $2.1 billion and adjusted EBITDA up 3% to $274 million, while reaffirming full-year guidance for sales and adjusted EBITDA.
U.S. stocks ended the week mixed after August jobs data beat expectations, with employers adding 162,000 positions and unemployment holding at 4.1%, boosting bets the Federal Reserve could raise rates in September.
BRP said second-quarter revenue was $2.2 billion and normalized EBITDA was $139 million, with results ahead of expectations despite a $145 million net tariff impact. The company lifted full-year revenue and normalized EPS guidance.
AI said revenue exceeded guidance at $52.4 million, gross margin rose to 50%, free cash flow turned positive and federal bookings increased 138% year over year.